Updated on 4 September 2026
Great Bay Bio
CFO at Great Bay Bio Limited
China (Hong Kong)
About
AI enabled Acceleration of Preclinical Biologic Drug Development
GBB’s Belt & Road AI Preclinical Acceleration Platform helps local pharma and research partners turn promising biologic ideas into development-ready programs through AI, wet-lab validation, early CMC and country-led capability building.
Project Location
- China (Hong Kong)
Project Format
- Private Project
Go Global Project
- Yes
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Investment / Financing Discussion
Main Project Sector
- Technology
Investment Capital Required
- 10,000,001 to 25,000,000 USD
Interested Format of Cooperation
- Direct Equity Investment
Preferred Financing Model
- Debt
- Equity
Type(s) of Last Financing Round of the project (if Applicable)
- Equity (private)
Main Service(s) Required
- Professional Services
Similar opportunities
Project
AI enabled Acceleration of Preclinical Biologic Drug Development
- No
- Yes
- Equity
- Bio-Tech
- Technology
- Private Project
- Equity (private)
- Financial Services
- Partner Identification
- Direct Equity Investment
- 10,000,001 to 25,000,000 USD
- Private Equity & Venture Capital
Kingsley Leung
Chairman & Co-founder at Great Bay Bio Limited
China (Hong Kong)
Project
World-leading Elastic Textile-PCB
- No
- Yes
- IoT
- Equity
- Technology
- Private Project
- Venture Capital (VC)
- Professional Services
- Partner Identification
- Direct Equity Investment
- Intelligent Manufacturing
- 1,000,001 to 2,500,000 USD
- 10,000,001 to 25,000,000 USD
Dong Wang
CEO at Easenory Technology Limited
China (Hong Kong)
Project
- Yes
- Yes
- IoT
- Equity
- E-payment
- Technology
- E-Business
- Bootstrapping
- Cloud Solution
- Private Project
- Big Data Solution
- 500,000 USD or Below
- Professional Services
- Direct Equity Investment
- Intelligent Manufacturing
- Investment / Financing Discussion
jade Jiang
Founder at VISLAND
China (Hong Kong)